Skip to content

Perceptions of Leadership in Quality Culture for Infection Prevention Among Intensive Care Nurses and Unit-Based Assessment of Antimicrobial Resistance Indicators in Intensive Care Units

Perceptions of Leadership in Quality Culture for Infection Prevention Among Intensive Care Nurses and Unit-Based Assessment of Antimicrobial Resistance Indicators in Intensive Care Units

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07782372
Enrollment
127
Registered
2026-08-24
Start date
2026-09-01
Completion date
2026-12-30
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthcare-associated Infections, Infection Prevention and Control, Quality Culture and Leadership in Intensive Care

Keywords

Intensive care nurses, Infection prevention and control, Quality culture, Leadership

Brief summary

This study aims to examine intensive care nurses' perceptions of leadership in quality culture for infection prevention and to investigate antimicrobial resistance indicators at the intensive care unit level. Healthcare-associated infections (HAIs) remain a major global patient safety problem and are associated with prolonged hospital stays, increased healthcare costs, and higher mortality. The increasing prevalence of antimicrobial resistance (AMR) further complicates infection prevention and patient care. Intensive care units are particularly vulnerable to healthcare-associated infections and antimicrobial resistance because of the high frequency of invasive procedures, the vulnerability of critically ill patients, and the extensive use of broad-spectrum antibiotics. Nurses play a central role in infection prevention and antimicrobial stewardship because they are continuously involved in patient care. However, previous studies have reported a gap between nurses' knowledge of infection prevention and adherence to recommended practices in clinical settings. Organizational culture and leadership may contribute to this gap. Most previous studies have focused on healthcare professionals' self-reported perceptions of infection prevention. However, limited evidence is available regarding the relationship between nurses' perceptions of leadership and quality culture and objective antimicrobial resistance indicators at the intensive care unit level. Therefore, this study will assess nurses' perceptions using the Leadership in Quality Culture for Infection Prevention (LCQ-IP) instrument and examine their relationship with retrospective microbiological data from the participating intensive care units, including antimicrobial resistance rates and resistance profiles. The findings may provide evidence on the role of organizational leadership and quality culture in infection prevention and antimicrobial resistance management in intensive care settings.

Interventions

None listed

Sponsors

Yeliz Sapulu Alakan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
No minimum to 125 Years
Healthy volunteers
No

Inclusion criteria

* Nurses who have been actively working in an intensive care unit for at least 1 year. * Nurses who voluntarily agree to participate in the study.

Exclusion criteria

* Student nurses or nursing interns. * Nurses working temporarily or on a rotational basis in the intensive care unit. * Nurses who have been actively working in an intensive care unit for at least 1 year.

Design outcomes

Primary

MeasureTime frameDescription
Leadership in Quality Culture for Infection Prevention (LCQ-IP) score among intensive care nursesBaselineLeadership for a culture of quality in infection prevention will be assessed using the Turkish version of the Leading a Culture of Quality for Infection Prevention Scale. The scale consists of 16 items rated on a 5-point Likert scale. Total scores range from 16 to 80, with higher scores indicating a more positive perception of leadership for a culture of quality in infection prevention.

Secondary

MeasureTime frame
Antimicrobial Susceptibility Profiles of Bacterial Isolates from Intensive Care UnitsThe 1-year period preceding study enrollment

Contacts

CONTACTYeliz Alakan, PhD lecturer
yelizsapulu@uludag.edu.tr90 505 850 0222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 25, 2026